Neuromodulation Devices Market Global Industry Analysis and Forecast Neuromodulation Devices Market | Page 7

Neuromodulation Devices Market
Neuromodulation Devices Market: Region-wise Outlook
Neuromodulation devices market is segmented into seven regions, North America, Latin America,
Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa.North
America is the most attractive market due to increase in the end use of devices, awareness among
people and high prevalence of disease conditions such as Parkinson’s disease, chronic pain, epilepsy.
Followed by which is Western Europe. Asia-Pacific region is expected to be fastest growing due to
increasing population, change in lifestyle, and government initiative to aware the people regarding the
neurological disorders and their treatments. Japan is also an attractive market for neuromodulation
devices due to ageing population and increase in the approval rate of neuromodulation devices by
Pharmaceutical and Medical Devices Agency.
Full Report Analysis@ http://www.futuremarketinsights.com/reports/neuromodulation-devices-market
Neuromodulation Devices Market: Key Market Participants
Some of the market participants in the global neuromodulation devices market are Medtronic,
Accellent, BioControl Medical, Boston Scientific Corporation, DynaMD, Nevro Corp, NeuroSigma, Inc.,
NeuroPace, Inc., St. Jude Medical, Inc. Soterix Medical, Inc. and Synapse Biomedical, Inc.,. These
companies are focusing on miniaturizationof the neuromodulation devices and advancement of the
technology.
©2015 Future Market Insights, All Rights Reserved
7